Abstract

Pharmaceutical industry is highly capital-intensive Industry. After economic liberalization most of the Indian company raise fund for their new projects through capital market by issuing shares. However, capital markets are highly volatile and investors need to have close eye on the market for getting maximum return. In the present study, the stock prices of three pharmaceutical companies namely CIPALA, SUNFARAMA, DIVISLAB were studied for their performances in the capital market of Bombay Stock Exchange (BSE). The stock price data of these companies are obtained at monthly time step from BSE website for the duration January 2011 to March 2022. The data was analyzed using various statistical methods such as descriptive statistics, simple moving average (SMA), money flow index (MFI), relative strength index (RSI) and beta Index. The results showed that stock of DIVISLAB is best performer followed by CIPLA and SUNPHARMA. This analysis also provides several clues to investors for making perfect decision on holding or buying or selling the stock during a particular signal revealed from statistical indices used in the study.